Skip to main content

Covalon Technologies Ltd(COV-X)
TSX Venture

Today's Change
Delayed Last Update

Covalon Announces Improved First Quarter Fiscal 2023 Results

PR Newswire - Thu Feb 23, 2023

Revenue growth of 25%, significant margin improvement and strong balance sheet

MISSISSAUGA, ON, Feb. 23, 2023 /PRNewswire/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced its first quarter fiscal 2023 results for the period ended December 31, 2022.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe